These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 33828594)
1. Bayesian estimation of pharmacokinetic parameters: an important component to include in the teaching of clinical pharmacokinetics and therapeutic drug monitoring. Brocks DR; Hamdy DA Res Pharm Sci; 2020 Dec; 15(6):503-514. PubMed ID: 33828594 [TBL] [Abstract][Full Text] [Related]
2. Use of a common spreadsheet program to demonstrate the ability of Bayesian forecasting to estimate the pharmacokinetic parameters of antibiotics. Brocks DR; Wang M J Pharm Pharmacol; 2023 Oct; 75(10):1378-1387. PubMed ID: 37478874 [TBL] [Abstract][Full Text] [Related]
3. Developing population pharmacokinetic parameters for high-dose methotrexate therapy: implication of correlations among developed parameters for individual parameter estimation using the Bayesian least-squares method. Watanabe M; Fukuoka N; Takeuchi T; Yamaguchi K; Motoki T; Tanaka H; Kosaka S; Houchi H Biol Pharm Bull; 2014; 37(6):916-21. PubMed ID: 24882404 [TBL] [Abstract][Full Text] [Related]
4. Generation of pharmacokinetic data during routine therapeutic drug monitoring: Bayesian approach vs. pharmacokinetic studies. el Desoky E; Meinshausen J; Bühl K; Engel G; Harings-Kaim A; Drewelow B; Klotz U Ther Drug Monit; 1993 Aug; 15(4):281-8. PubMed ID: 8236362 [TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetics and Bayesian estimation of mycophenolic acid concentrations in stable renal transplant patients. Le Guellec C; Bourgoin H; Büchler M; Le Meur Y; Lebranchu Y; Marquet P; Paintaud G Clin Pharmacokinet; 2004; 43(4):253-66. PubMed ID: 15005639 [TBL] [Abstract][Full Text] [Related]
6. A Bayesian formulation of the Kalman filter applied to the estimation of individual pharmacokinetic parameters. Botsman K; Tickle K; Smith JD Comput Biomed Res; 1997 Apr; 30(2):83-94. PubMed ID: 9167082 [TBL] [Abstract][Full Text] [Related]
7. A comparison of two sparse sampling population pharmacokinetic approaches for the estimation of pharmacokinetic parameters in children. Mahmood I; Tammara V Int J Clin Pharmacol Ther; 2004 Apr; 42(4):240-5. PubMed ID: 15124982 [TBL] [Abstract][Full Text] [Related]
8. Individualising aminoglycoside dosage regimens after therapeutic drug monitoring: simple or complex pharmacokinetic methods? Tod MM; Padoin C; Petitjean O Clin Pharmacokinet; 2001; 40(11):803-14. PubMed ID: 11735603 [TBL] [Abstract][Full Text] [Related]
9. A Bayesian approach for the estimation of pharmacokinetic parameters in children. Mahmood I Am J Ther; 2003; 10(2):88-92. PubMed ID: 12629586 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of Bayesian estimation of pharmacokinetic parameters. Tsuchiwata S; Mihara K; Yafune A; Ogata H Ther Drug Monit; 2005 Feb; 27(1):18-24. PubMed ID: 15665741 [TBL] [Abstract][Full Text] [Related]
11. Bayesian estimation of methotrexate pharmacokinetic parameters and area under the curve in children and young adults with localised osteosarcoma. Rousseau A; Sabot C; Delepine N; Delepine G; Debord J; Lachâtre G; Marquet P Clin Pharmacokinet; 2002; 41(13):1095-104. PubMed ID: 12403645 [TBL] [Abstract][Full Text] [Related]
12. Progress in strategies for dosage regimen individualization. Marouani H; Woloch C; Benay S; Frances N; Iliadis A Curr Top Med Chem; 2012; 12(15):1669-77. PubMed ID: 22978335 [TBL] [Abstract][Full Text] [Related]
14. Population kinetics and conditional assessment of the optimal dosage regimen using the P-PHARM software package. Gomeni R; Pineau G; Mentré F Anticancer Res; 1994; 14(6A):2321-6. PubMed ID: 7825966 [TBL] [Abstract][Full Text] [Related]
15. Estimation of population pharmacokinetic parameters in the presence of non-compliance. Mu S; Ludden TM J Pharmacokinet Pharmacodyn; 2003 Feb; 30(1):53-81. PubMed ID: 12800807 [TBL] [Abstract][Full Text] [Related]
16. Development of a population pharmacokinetic model for carbamazepine based on sparse therapeutic monitoring data from pediatric patients with epilepsy. Carlsson KC; Hoem NO; Glauser T; Vinks AA Clin Ther; 2005 May; 27(5):618-26. PubMed ID: 15978311 [TBL] [Abstract][Full Text] [Related]
17. Performance comparison of first-order conditional estimation with interaction and Bayesian estimation methods for estimating the population parameters and its distribution from data sets with a low number of subjects. Pradhan S; Song B; Lee J; Chae JW; Kim KI; Back HM; Han N; Kwon KI; Yun HY BMC Med Res Methodol; 2017 Dec; 17(1):154. PubMed ID: 29191177 [TBL] [Abstract][Full Text] [Related]
18. Towards precision dosing of vancomycin: a systematic evaluation of pharmacometric models for Bayesian forecasting. Broeker A; Nardecchia M; Klinker KP; Derendorf H; Day RO; Marriott DJ; Carland JE; Stocker SL; Wicha SG Clin Microbiol Infect; 2019 Oct; 25(10):1286.e1-1286.e7. PubMed ID: 30872102 [TBL] [Abstract][Full Text] [Related]
19. Adaptive control methods for the dose individualisation of anticancer agents. Rousseau A; Marquet P; Debord J; Sabot C; Lachâtre G Clin Pharmacokinet; 2000 Apr; 38(4):315-53. PubMed ID: 10803455 [TBL] [Abstract][Full Text] [Related]